Multi-institutional prospective registry of initial chemotherapy combined with hyperthermia for locally advanced pancreatic cancer (JSTM-PAN01LA)

Multi-institutional prospective registry of initial chemotherapy combined with hyperthermia for locally advanced pancreatic cancer (JSTM-PAN01LA) - JSTM-PAN01LA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050717

Enrollment

Registered

2023-03-30

Start date

2022-11-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally advanced pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Locally advanced pancreatic cancer, no distant metastases. Patients diagnosed with adenocarcinoma by tissue biopsy or cytology. However, patients within 2 months after the start of first chemotherapy are allowed.

Exclusion criteria

Exclusion criteria: Active multiple cancers (synchronous multiple cancers and heterochronic multiple cancers with a disease-free period of 5 years or less). However, epithelial cancer, lesions equivalent to intramucosal cancer, and skin cancer that are considered curable by local treatment are not included as active overlapping cancers.

Design outcomes

Primary

Measure	Time frame
Progression-free survival	—

Secondary

Measure	Time frame
overall survival Side effects	—

Countries

Japan

Contacts

Public ContactTakayuki Ohguri

University Hospital of Occupational and Environmental Hralth Department of Therapeutic Radiology

ogurieye@med.uoeh-u.ac.jp093-603-1611

Outcome results